Novartis Bioventures Ltd, 10% Owner at Tokai Pharmaceuticals Inc (TKAI), sold 1,120 shares at $14.27 ($16K) on 2015-06-16, disclosed to the SEC on 2015-06-18.
Open-market sale of $16k TKAI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |